Product Information
METRONIDAZOLE VAGINAL 0.75% GL is a generic product labeled by Oceanside Pharmaceuticals, priced at $0.1810 per GM under NDC 68682045570. Its NADAC has been published 539 times since Jun 10, 2015.
FDA first approved this application on Aug 17, 1992.
Strength
7.5 mg/g
Manufacturer
Oceanside PharmaceuticalsNDC
68682045570
Classification
Generic
Dosage Form
GEL
Route
VAGINAL
Effective Date
9/17/2025
Active Ingredients
METRONIDAZOLEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020208FDA Approved
8/17/1992
On Market Since
4/1/2015
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE VAGINAL 0.75% GL has been published 539 times since Jun 10, 2015, and over the history we have for it it has declined 41.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1810 per GM |
|---|---|
| All-time high | $1.4487 (Feb 10, 2016) |
| All-time low | $0.1612 (Nov 20, 2024) |
| Median price | $0.8248 |
| Average price | $0.7638 |
| Largest weekly change | +114.7% (Aug 19, 2015) |
| Weeks tracked | 539 |
| Tracking since | Jun 10, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-64.8%
5Y
-78.4%
All
-41.1%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metronidazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE VAGINAL 0.75% GL?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE VAGINAL 0.75% GL, manufactured by Oceanside Pharmaceuticals, is $0.1810 per GM (NDC 68682045570), effective Oct 1, 2025.
How has the price of METRONIDAZOLE VAGINAL 0.75% GL changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE VAGINAL 0.75% GL has declined 41.1%. It has been tracked across 539 weekly CMS publications since Jun 10, 2015.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE VAGINAL 0.75% GL?
Since Jun 10, 2015, the NADAC for METRONIDAZOLE VAGINAL 0.75% GL has ranged from a low of $0.1612 (Nov 20, 2024) to a high of $1.4487 (Feb 10, 2016), with a median of $0.8248 per GM.
Are there cheaper alternatives to METRONIDAZOLE VAGINAL 0.75% GL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METRONIDAZOLE VAGINAL 0.75% GL, is $0.1406 per GM — about 22% below METRONIDAZOLE VAGINAL 0.75% GL.
Who manufactures METRONIDAZOLE VAGINAL 0.75% GL?
METRONIDAZOLE VAGINAL 0.75% GL (NDC 68682045570) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.